Skip to main content
High RiskFDAfda-F-1073-2022UNDECLARED ALLERGEN

SE Grocers Cheesecake SAMPLER New York Style, Chocolate Silk, Strawberry Swirl, Turtle - NO ARTIFICIAL FLAVORS - NET WT 32 OZ (2 LB) 907g...

Category
Units Affected
1,007
Recall Date
April 26, 2022
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1073-2022.

The firm was notified by a customer that the label does not declare pecans in its ingredient statement.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1073-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Atlanta Cheesecake Company Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1073-2022.

Atlanta Cheesecake Company LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Atlanta Cheesecake Company Llc Recall FAQ

Atlanta Cheesecake Company Llc is the subject of a dairy safety report: SE Grocers Cheesecake SAMPLER New York Style, Chocolate Silk, Strawberry Swirl, Turtle - NO ARTIFICIAL FLAVORS - NET WT 32 OZ (2 LB) 907g.... The notice was published on April 26, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 1,007 units are potentially affected.